Publications by authors named "D Perol"

Claim this Profile
E
Enhancing confidence in complex health technology assessments by using real-world evidence: highlighting existing strategies for effective drug evaluation.
Alison Antoine, Katia Desroziers, Julien Dupin, David Pérol, Rémy Choquet

BMC Med Res Methodol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03.
Olivier Trédan, Delphine Loirat, Sylvie Chabaud, Philippe Toussaint, Thierry Petit

Breast· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Critical evaluation of the ProfiLER-02 study design and outcomes.
Olivier Trédan, Marie-Sarah Cabrillac, Sylvie Chabaud, Gwenaelle Garin, David Pérol

Nat Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compression therapy with surgical gloves compared to cold therapy with frozen gloves in preventing paclitaxel-induced peripheral neuropathy: Results from the prospective ELEGANT trial in patients with breast cancer.
Brunhilde Hanvic, Aurélia Joureau-Chabert, Yaëlle Ouldbey, Philippe Toussaint, Emilie Chanel

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort.
R Varnier, D Pérol, W Jacot, A Mailliez, V Diéras

ESMO Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis